within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G04B_Urologicals.G04BE06_Moxisylyte;
model Moxisylyte 
   extends Pharmacolibrary.Drugs.ATC.G.G04BE06;

  annotation(Documentation(
    info ="<html><body><p>Moxisylyte (also known as thymoxamine) is an alpha-adrenergic antagonist that was previously used to treat erectile dysfunction and Raynaud's phenomenon by producing vasodilation. It is not widely approved or used in current clinical practice.</p><h4>Pharmacokinetics</h4><p>No published clinical pharmacokinetic studies specific to moxisylyte in humans with explicit parameters for adults, males, or patients with erectile dysfunction or Raynaud's phenomenon were found. The following pharmacokinetic parameters are estimated based on general knowledge for orally administered alpha-blockers and analogous agents.</p><h4>References</h4><ol><li><p>Costa, P, et al., &amp; Galtier, M (1993). Multiple-dose pharmacokinetics of moxisylyte after oral administration to healthy volunteers. <i>Journal of pharmaceutical sciences</i> 82(9) 968–971. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600820920&quot;>10.1002/jps.2600820920</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8229699/&quot;>https://pubmed.ncbi.nlm.nih.gov/8229699</a></p></li><li><p>Costa, P, et al., &amp; Sarrazin, B (1992). Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and oral administration. <i>Journal of pharmaceutical sciences</i> 81(12) 1223–1226. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600811220&quot;>10.1002/jps.2600811220</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1491345/&quot;>https://pubmed.ncbi.nlm.nih.gov/1491345</a></p></li><li><p>Marquer, C, &amp; Bressolle, F (1998). Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence. <i>Fundamental &amp; clinical pharmacology</i> 12(4) 377–387. DOI:<a href=&quot;https://doi.org/10.1111/j.1472-8206.1998.tb00961.x&quot;>10.1111/j.1472-8206.1998.tb00961.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9711459/&quot;>https://pubmed.ncbi.nlm.nih.gov/9711459</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Moxisylyte;
